We are live on ! Find out more
BIOT

Biotech Acquisition Company Class A Ordinary Shares

Delisted

BIOT was delisted on the 2nd of February, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
GCL
1
Glazer Capital LLC
New York
$23.1M -$10.9K -1,090 -0%
AC
2
Aristeia Capital
Connecticut
$15.4M +$3.75M +375,000 +33%
Hudson Bay Capital Management
3
Hudson Bay Capital Management
Connecticut
$12.7M
Marshall Wace
4
Marshall Wace
United Kingdom
$10.2M
SCM
5
Saba Capital Management
New York
$9.75M
D.E. Shaw & Co
6
D.E. Shaw & Co
New York
$9.38M
CCP
7
Corbin Capital Partners
New York
$9.37M
RA
8
RiverPark Advisors
New York
$8.07M
Millennium Management
9
Millennium Management
New York
$7.14M
HSBC Holdings
10
HSBC Holdings
United Kingdom
$6.45M
FTCM
11
Fir Tree Capital Management
New York
$6.42M -$109K -10,931 -2%
PAMP
12
Polar Asset Management Partners
Ontario, Canada
$6.23M +$501K +50,000 +9%
MI
13
MMCAP International
Cayman Islands
$6.05M
AWG
14
Alpha Wave Global
New York
$5.38M
WCMNY
15
Westchester Capital Management (New York)
New York
$5.26M
WRBC
16
W.R. Berkley Corp
Connecticut
$4.92M +$1.99M +199,032 +69%
RCM
17
Radcliffe Capital Management
Pennsylvania
$4.61M
DKCM
18
Davidson Kempner Capital Management
New York
$4.54M
Nomura Holdings
19
Nomura Holdings
Japan
$4.04M
MF
20
Magnetar Financial
Illinois
$3.84M
State of Wisconsin Investment Board
21
State of Wisconsin Investment Board
Wisconsin
$3.64M
RL
22
RPO LLC
Connecticut
$3.63M -$200K -20,012 -5%
AA
23
AQR Arbitrage
Connecticut
$3.55M
SC
24
Sculptor Capital
New York
$3.04M
ACA
25
Arena Capital Advisors
California
$3.03M